Animal placental protein are obtained from the placental membrane of animals. These proteins are rich in amino acids, hormones, peptides and other essential nutrients. They are used to manufacture dietary supplements, cosmetic and personal care products. They help enhance muscle growth, boost immunity and improve skin health.
Market key trends:
One of the major market trends is the growing demand for organic and natural supplements. Consumers are increasingly preferring supplements made from plant and animal extracts over chemically synthesized ones due to rising health consciousness. Animal placental protein are considered natural supplements as they contain essential growth factors and nutrients in their native form. Their consumption helps provide both nutritional and physiological benefits. Additionally, they stimulate collagen production and promote anti-aging effects when consumed orally or applied topically. This has spurred their adoption in anti-aging nutraceuticals and cosmetic products in recent years.
The global Animal Placental Protein Market is estimated to be valued at US$ 551.9 Mn in 2023 and is expected to exhibit a CAGR of 5.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Porter’s Analysis
Threat of new entrants: Low capital requirements and established buyers help new companies easily enter the market. However, dominant players and consumer loyalty pose barriers.
Bargaining power of buyers: Individual consumers have low bargaining power but large buyers like food companies can negotiate lower prices due to the concentrated nature of supply.
Bargaining power of suppliers: Few global suppliers exist for this market resulting in higher bargaining power. Suppliers can influence prices.
Threat of new substitutes: Potential substitutes include other protein sources but none perfectly mimic placental properties, restricting threat of substitution.
Competitive rivalry: Major players compete on pricing and quality leading to price wars and new product launches intensifying competition in the animal placental protein market.
SWOT Analysis
Strength: Placental extracts are a rich source of proteins, bioactive compounds and growth factors with anti-aging benefits creating strong demand.
Weakness: Limited awareness among consumers regarding Placental benefits. Suppliers depend on availability of raw materials from livestock industry.
Opportunity: Growing demand for nutraceuticals and functional foods among health-conscious customers presents an opportunity. Applications in cosmetics and pharmaceuticals industries also expand opportunities.
Threats: Stringent regulations regarding plasma collection can delay new product approvals. Alternative proteins gaining popularity pose a threat.
Key Takeaways
The global Animal Placental Protein Market Demand is expected to witness high growth, exhibiting CAGR of 5.6% over the forecast period, due to increasing demand for specialized nutrition and nutraceuticals. North America dominates the market currently due to high health awareness and strong demand for nutritious food supplements in the region. The Asia Pacific region is expected to grow at the fastest pace due to rising incomes, westernization of diet and expanding middle class in the region.
Key players operating in the Animal Placental Protein market are Sigma-Aldrich Corporation (Now part of Merck KGaA), Biotain Pharma Co., Ltd., New Zealand Health Food Company Limited, XABC Biotech Co., Ltd., BIOFAC A/S, Chaitanya Biologicals Pvt. Ltd., Serolab SA, Auckland BioSciences Limited, ANZCO Foods Limited & Biocontinental Co., Ltd. These companies are focusing on new product launches, R&D activities and enhancing production capacities to strengthen their market position.
Get More Insights On This Topic: https://www.ukwebwire.com/industry-boosts-prospects-for-animal-placental-protein-market/
